Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep 1;6(5):1087-93.
doi: 10.1177/193229681200600512.

The relationships between common measures of glucose meter performance

Affiliations

The relationships between common measures of glucose meter performance

Daniel R Wilmoth. J Diabetes Sci Technol. .

Abstract

Background: Glucose meter performance is commonly measured in several different ways, including the relative bias and coefficient of variation (CV), the total error, the mean absolute relative deviation (MARD), and the size of the interval around the reference value that would be necessary to contain a meter measurement at a specified probability. This fourth measure is commonly expressed as a proportion of the reference value and will be referred to as the necessary relative deviation. A deeper understanding of the relationships between these measures may aid health care providers, patients, and regulators in comparing meter performances when different measures are used.

Methods: The relationships between common measures of glucose meter performance were derived mathematically.

Results: Equations are presented for calculating the total error, MARD, and necessary relative deviation using the reference value, relative bias, and CV when glucose meter measurements are normally distributed. When measurements are also unbiased, the CV, total error, MARD, and necessary relative deviation are linearly related and are therefore equivalent measures of meter performance.

Conclusions: The relative bias and CV provide more information about meter performance than the other measures considered but may be difficult for some audiences to interpret. Reporting meter performance in multiple ways may facilitate the informed selection of blood glucose meters.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Six meter measurement distributions with TE0.975 = 20 mg/dl (1.1 mmol/liter). The reference value, relative bias, and CV corresponding to each distribution appear above the distribution. The reference value for each distribution is also labeled in bold on the horizontal axis. The CVs have been rounded to three decimal places. The shaded area under each curve corresponds to meter measurements falling outside of zone A in Clarke’s error grid. The proportion of the area under each curve that is shaded is the proportion of meter measurements that would fall outside of zone A.
Figure 2
Figure 2
Six meter measurement distributions with MARD = 0.08. The reference value, relative bias, and CV corresponding to each distribution appear above the distribution. The reference value for each distribution is also labeled in bold on the horizontal axis. The CVs have been rounded to three decimal places. The shaded area under each curve corresponds to meter measurements falling outside of zone A in Clarke’s error grid. The proportion of the area under each curve that is shaded is the proportion of meter measurements that would fall outside of zone A.
Figure 3
Figure 3
Six meter measurement distributions with reldev0.95 = 0.20. The reference value, relative bias, and CV corresponding to each distribution appear above the distribution. The reference value for each distribution is also labeled in bold on the horizontal axis. The CVs have been rounded to three decimal places. The shaded area under each curve corresponds to meter measurements falling outside of zone A in Clarke’s error grid. The proportion of the area under each curve that is shaded is the proportion of meter measurements that would fall outside of zone A.

References

    1. Centers for Disease Control and Prevention (CDC) Self-monitoring of blood glucose among adults with diabetes--United States, 1997-2006. MMWR Morb Mortal Wkly Rep. 2007;56(43):1133–1137. - PubMed
    1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet. 1998;352(9131):837–853. - PubMed
    1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986. - PubMed
    1. Ginsberg BH. Factors affecting blood glucose monitoring: sources of errors in measurement. J Diabetes Sci Technol. 2009;3(4):903–913. - PMC - PubMed
    1. Breton MD, Kovatchev BP. Impact of blood glucose self-monitoring errors on glucose variability, risk for hypoglycemia, and average glucose control in type 1 diabetes: an in silico study. J Diabetes Sci Technol. 2010;4(3):562–570. - PMC - PubMed

Publication types

MeSH terms